Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review

dc.contributor.authorAlvarenga, C.
dc.contributor.authorLa Banca, R.
dc.contributor.authorNeris, R.
dc.contributor.authorde Cássia Sparapani, V.
dc.contributor.authorFuentealba-Torres, M.
dc.contributor.authorCartagena-Ramos, D.
dc.contributor.authorLeal, C.
dc.contributor.authorEsper, M.
dc.contributor.authorNascimento, L.
dc.date.accessioned2022-04-21T15:58:07Z
dc.date.available2022-04-21T15:58:07Z
dc.date.issued2022-02
dc.descriptionIndexación: Scopus.es
dc.description.abstractBackground: Among the treatments for type 1 diabetes mellitus (T1DM), Continuous Subcutaneous Insulin Infusion (CSII) is a device that infuses insulin through the subcutaneous tissue in an uninterrupted manner and that comes closest to the physiological secretion of insulin. The use of CSII can provide the family with greater security and children and adolescents have more autonomy in relation to the treatment of T1DM. There is a lack of reviews that systematically gather the mounting evidence about the use of CSII in children and adolescents with T1DM. Therefore, the aim of this review was to group and describe primary and secondary studies on the use of CSII in children and adolescents with T1DM. Methods: A systematic mapping review was performed based on searches in the following databases: PubMed, Embase, CINAHL, Lilacs and PsycINFO, using a combination of descriptors and keywords. The screening of the studies was carried out with the aid of the Rayyan software and reading in full was conducted independently by two reviewers. The data extraction of the studies was performed using an extraction tool adapted and validated by researchers specialized in diabetes. The data were analyzed according to the content analysis technique. The map from geocoding of the studies was produced using the ArcGis 10.5 software. Results: A total of 113 studies were included in the review, including primary studies, literature reviews and gray literature publications. The content analysis of the results of the studies allowed for the identification of four categories: 1) metabolic control; 2) support networks; 3) benefits of using CSII; and 4) challenges of using CSII, each category having its respective subcategories. The review also made it possible to conduct a rigorous mapping of the literature on the use of CSII considering the location of development and the design of the studies. Conclusions: The use of CSII should be indicated by health professionals able to prepare children, adolescents, and their families for the treatment of T1DM, and, despite being a technological device, it may not be suitable for the entire pediatric population.es
dc.description.urihttps://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-022-00950-7
dc.identifier.citationBMC Endocrine Disorders,Volume 22, Issue 1,December 2022, Article number 43es
dc.identifier.doi10.1186/s12902-022-00950-7
dc.identifier.issn1472-6823
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/22350
dc.language.isoenes
dc.publisherBioMed Central Ltdes
dc.rights.licenseAttribution 4.0 International (CC BY 4.0)
dc.rights.urihttps://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-022-00950-7#rightslink
dc.subjectAdolescentes
dc.subjectChildes
dc.subjectDiabetes mellitus, type 1es
dc.subjectInsulin infusion systemses
dc.subjectPediatric nursinges
dc.subjectReviewes
dc.subjectPatient with Type 1 Diabeteses
dc.subjectInsulin Dependent Diabetes Mellituses
dc.subjectInsulinses
dc.titleUse of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping reviewes
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Alvarenga_Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus.pdf
Tamaño:
2.19 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLES
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: